血管アクセス機器の世界市場：2023～2030年

世界の血管アクセス機器市場は、予測期間（2023～2030年）にCAGR 6.11％で成長すると予測されています。同市場の成長は、世界中で医療費用が増加していることに起因しています。血管アクセス機器のような革新的な医療機器に対する需要は、先進国と発展途上国の両方における医療支出の増加によってもたらされています。それに伴い、市場各社は末梢血管アクセスシステムの需要に応える新製品を発表しています。例えば、2023年4月、BD（Becton, Dickinson and Company）は、超音波ガイド方式で静脈アクセス針刺しの有効性と安全性を高めることができるBDプレビュー（TM）II末梢血管アクセスシステムを発売しました。BDプレヴューII血管アクセスシステムにはいくつかの特徴があります。リアルタイムの針深度マーカー、臨床医が視野や手技を変えることなく使用できる特殊プローブ、BDキュー（TM）ニードルトラッキング技術による針軌跡のバーチャル表示、最適な静脈カテーテルの長さのための血管評価ツールなどです。

セグメント別の展望

病院・クリニック向けが世界の血管アクセス機器市場で大きなシェアを占める見込み

エンドユーザーのうち、病院・クリニックサブセグメントが世界の血管アクセス機器市場でかなりのシェアを占めると予想されています。このセグメントの成長は、血管アクセス機器に対する需要の高まりに起因しています。医療施設は、血管外科治療やインターベンショナル治療におけるケアの質を向上させようと努力しており、これが高度な血管アクセスツールに対する需要を高めると予測されています。このような機器は血管疾患の診断と治療に必要であるため、治療レジメンにおいて重要な役割を果たします。そのため、市場各社は入院血管治療の需要に応える新製品を投入しています。例えば、2023年3月、米国外科学会（ACS）は、血管外科学会（SVS）と共同で、入院患者の血管外科治療およびインターベンション治療に参加する患者を対象に、参加病院が治療成績を向上させ、最も効果的な治療を提供できるよう支援することを目的とした新しい国家品質検証プログラムを開始しました。

地域別展望

世界の血管アクセス機器市場は、北米（米国、カナダ）、欧州（英国、イタリア、スペイン、ドイツ、フランス、その他の欧州地域）、アジア太平洋（インド、中国、日本、韓国、その他アジア地域）、世界のその他の中東・アフリカ（中東およびアフリカ、ラテンアメリカ）を含む地域別にさらに細分化されています。なかでもアジア太平洋は、同地域で確立されたネットワークを持つ現地の流通業者が市場を拡大させ、血管アクセス機器業界における競合優位性が市場を拡大させることができるため、世界全体で突出したシェアを占めると予想されています。

北米地域は世界の血管アクセス機器市場で大きなCAGRで成長する見込み

すべての地域の中で、北米地域は予測期間中にかなりのCAGRで成長すると予測されています。この地域の成長は、血管アクセスカテーテルがこの地域で頻繁に使用されていることに起因しています。このデータは、末梢挿入型中心カテーテル、正中線カテーテル、動脈ラインなどの血管アクセスカテーテルが臨床で頻繁に使用されていることを示しています。同種の技術が不可欠であることを示しています。国立衛生研究所（政府）によると、2022年3月、血管アクセスカテーテルを挿入された全患者の53.1％は女性で、平均年齢は34.2歳、敗血症（90.2％）および心血管問題による重症治療サービスへの入院でした。初回穿刺の成功率は66％で、末梢挿入型中心静脈カテーテル、正中線カテーテル、動脈カテーテルの留置は91％～100％のエコーガイド下で行われました。正中線カテーテルの到達率は治療終了まで57％であったが、末梢留置型中心静脈カテーテルの平均留置期間は25.3日でした。カテーテル1日あたりの全体的な静脈炎発生率は2.03、末梢中心挿入機器の血液培養陽性率は1.9、血栓症発生率は0.50、動脈ライン血栓症発生率は11.7でした。入院患者の複雑さに応じて、前述の要素を合理的かつ構造的に治療的に使用することで、看護師を中心とした血管アクセス機器プログラムが懸念していることを報告しました。効率的なフォローアップと管理メカニズムを通じて感染率と血栓症を減らすためには、改善戦略を実行に移す必要があります。

さらに、この市場の成長は、臨床上のアドバイスと地域全体での採用に起因しています。特定の血管アクセス機器は、臨床上のアドバイスや医療専門家のサポートに応じて採用されることがあります。市場拡大は、Arrow Pressure Injectable Midline製品に対する好意的なレビューや提案によって促進される可能性があります。2022年9月、Teleflex Incorporatedは、ライン識別の不確実性を低減する取り組みとして、米国とカナダで新しいArrow Pressure Injectable Midlineポートフォリオを発表しました。臨床医は、標準的なArrow Midlineと、抗菌・抗血栓性のArrowg+ard Blue Advance Midlineのどちらかを選択することができ、どちらもシングルルーメンとダブルルーメンのデザインがあります。

目次

第1章 レポート概要

• 業界の現状分析と成長ポテンシャルの展望
• 調査方法とツール
• 市場内訳
  • セグメント別
  • 地域別

第2章 市場概要と洞察

• 調査範囲
• アナリスト洞察と現在の市場動向
  • 主な調査結果
  • 推奨事項
  • 結論

第3章 競合情勢

• 主要企業分析
• Access Vascular, Inc.
• B. Braun SE
• Becton, Dickinson, and Co.
• 主要戦略分析

第4章 市場セグメンテーション

• 血管アクセス機器の世界市場：機器タイプ別
  • 中心血管アクセス機器
    • 末梢挿入型中心静脈カテーテル
    • 経皮的非トンネルカテーテル
    • その他の中心血管アクセス機器
  • 末梢血管アクセス機器
    • 末梢カテーテル
    • 中間ラインカテーテル
    • その他の末梢血管アクセス機器
• 血管アクセス機器の世界市場：用途別
  • 薬剤投与
  • 輸液・栄養管理
  • 診断と検査
  • その他（救急・救命、静脈内治療）
• 血管アクセス機器の世界市場：エンドユーザー別
  • 直火式
  • 間接加熱式
  • 水駆動式
• 血管アクセス機器の世界市場：エンドユーザー別
  • 病院・クリニック
  • 診断センター
  • その他（在宅医療機関、高齢者ホーム、診断・画像診断センター）

第5章 地域別分析

• 北米
  • 米国
  • カナダ
• 欧州
  • 英国
  • ドイツ
  • イタリア
  • スペイン
  • フランス
  • その他の欧州
• アジア太平洋
  • 中国
  • インド
  • 日本
  • 韓国
  • その他のアジア太平洋
• 世界のその他の中東・アフリカ

第6章 企業プロファイル

• Baxter Healthcare Corp.
• Cook Group Inc.
• Fresenius Medical Care India Private Ltd.
• India Medtronic Pvt Ltd.
• Nipro Medical Corp.
• Siemens Healthineers co.
• Smiths Group
• Statementイントロダクション
• Teleflex Inc.
• Terumo Group

LIST OF TABLES

• 1. GLOBAL VASCULAR ACCESS DEVICES MARKET RESEARCH AND ANALYSIS BY DEVICE TYPE, 2022-2030 ($ MILLION)
• 2. GLOBAL CENTRAL VASCULAR ACCESS DEVICES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
• 3. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETERS VASCULAR ACCESS DEVICES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
• 4. GLOBAL OTHERS VASCULAR ACCESS DEVICES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
• 5. GLOBAL PERIPHERAL VASCULAR ACCESS DEVICES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
• 6. GLOBAL PERIPHERAL CATHETER VASCULAR ACCESS DEVICES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
• 7. GLOBAL MIDLINE CATHETER VASCULAR ACCESS DEVICES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
• 8. GLOBAL OTHERS VASCULAR ACCESS DEVICES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
• 9. GLOBAL VASCULAR ACCESS DEVICES MARKET RESEARCH AND ANALYSIS BY APPLICATION , 2022-2030 ($ MILLION)
• 10. GLOBAL VASCULAR ACCESS DEVICES IN ADMINISTRATION OF DRUGS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
• 11. GLOBAL VASCULAR ACCESS DEVICES IN ADMINISTRATION OF FLUID AND NUTRITION MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
• 12. GLOBAL VASCULAR ACCESS DEVICES IN DIAGNOTICS AND TESTING MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
• 13. GLOBAL VASCULAR ACCESS DEVICES IN OTHERS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
• 14. GLOBAL VASCULAR ACCESS DEVICES MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
• 15. GLOBAL VASCULAR ACCESS DEVICES FOR HOSPITAL AND CLINIC MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
• 16. GLOBAL VASCULAR ACCESS DEVICES FOR DIAGNOSTIC CENTERS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
• 17. GLOBAL VASCULAR ACCESS DEVICES FOR DIAGNOSTIC CENTERS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
• 18. GLOBAL VASCULAR ACCESS DEVICES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
• 19. NORTH AMERICAN VASCULAR ACCESS DEVICES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
• 20. NORTH AMERICAN VASCULAR ACCESS DEVICES MARKET RESEARCH AND ANALYSIS BY DEVICE TYPE, 2022-2030 ($ MILLION)
• 21. NORTH AMERICAN VASCULAR ACCESS DEVICES MARKET RESEARCH AND ANALYSIS BY APPLICATION , 2022-2030 ($ MILLION)
• 22. NORTH AMERICAN VASCULAR ACCESS DEVICES MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
• 23. EUROPEAN VASCULAR ACCESS DEVICES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
• 24. EUROPEAN VASCULAR ACCESS DEVICES MARKET RESEARCH AND ANALYSIS BY DEVICE TYPE, 2022-2030 ($ MILLION)
• 25. EUROPEAN VASCULAR ACCESS DEVICES MARKET RESEARCH AND ANALYSIS BY APPLICATION , 2022-2030 ($ MILLION)
• 26. EUROPEAN VASCULAR ACCESS DEVICES MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
• 27. ASIA- PACIFIC VASCULAR ACCESS DEVICES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
• 28. ASIA- PACIFIC VASCULAR ACCESS DEVICES MARKET RESEARCH AND ANALYSIS BY DEVICE TYPE, 2022-2030 ($ MILLION)
• 29. ASIA- PACIFIC VASCULAR ACCESS DEVICES MARKET RESEARCH AND ANALYSIS BY APPLICATION , 2022-2030 ($ MILLION)
• 30. ASIA- PACIFIC VASCULAR ACCESS DEVICES MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
• 31. REST OF THE WORLD VASCULAR ACCESS DEVICES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
• 32. REST OF THE WORLD VASCULAR ACCESS DEVICES MARKET RESEARCH AND ANALYSIS BY DEVICE TYPE, 2022-2030 ($ MILLION)
• 33. REST OF THE WORLD VASCULAR ACCESS DEVICES MARKET RESEARCH AND ANALYSIS BY APPLICATION , 2022-2030 ($ MILLION)
• 34. REST OF THE WORLD VASCULAR ACCESS DEVICES MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)

LIST OF FIGURES

• 1. GLOBAL VASCULAR ACCESS DEVICES MARKET SHARE BY DEVICE TYPE, 2022 VS 2030 (%)
• 2. GLOBAL CENTRAL VASCULAR ACCESS DEVICES MARKET SHARE BY REGION, 2022 VS 2030 (%)
• 3. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETERS VASCULAR ACCESS DEVICES MARKET SHARE BY REGION, 2022 VS 2030 (%)
• 4. GLOBAL PERCUTANEOUS NON-TUNNELED CATHETERS VASCULAR ACCESS DEVICES MARKET SHARE BY REGION, 2022 VS 2030 (%)
• 5. GLOBAL OTHERS VASCULAR ACCESS DEVICES MARKET SHARE BY REGION, 2022 VS 2030 (%)
• 6. GLOBAL PERIPHERAL VASCULAR ACCESS DEVICES MARKET SHARE BY REGION, 2022 VS 2030 (%)
• 7. GLOBAL PERIPHERAL CATHETER VASCULAR ACCESS DEVICES MARKET SHARE BY REGION, 2022 VS 2030 (%)
• 8. GLOBAL MIDLINE CATHETER VASCULAR ACCESS DEVICES MARKET SHARE BY REGION, 2022 VS 2030 (%)
• 9. GLOBAL OTHERS VASCULAR ACCESS DEVICES MARKET SHARE BY REGION, 2022 VS 2030 (%)
• 10. GLOBAL VASCULAR ACCESS DEVICES MARKET SHARE BY APPLICATION, 2022 VS 2030 (%)
• 11. GLOBAL VASCULAR ACCESS DEVICES IN ADMINISTRATION OF DRUGS MARKET SHARE BY REGION, 2022 VS 2030 (%)
• 12. GLOBAL VASCULAR ACCESS DEVICES IN ADMINISTRATION OF FLUID AND NUTRITION MARKET SHARE BY REGION, 2022 VS 2030 (%)
• 13. GLOBAL VASCULAR ACCESS DEVICES IN DIAGNOTICS AND TESTING MARKET SHARE BY REGION, 2022 VS 2030 (%)
• 14. GLOBAL VASCULAR ACCESS DEVICES IN OTHERS MARKET SHARE BY REGION, 2022 VS 2030 (%)
• 15. GLOBAL VASCULAR ACCESS DEVICES MARKET SHARE BY END-USER, 2022 VS 2030 (%)
• 16. GLOBAL VASCULAR ACCESS DEVICES FOR HOSPITAL AND CLINIC MARKET SHARE BY REGION, 2022 VS 2030 (%)
• 17. GLOBAL VASCULAR ACCESS DEVICES FOR DIAGNOSTIC CENTERS MARKET SHARE BY REGION, 2022 VS 2030 (%)
• 18. GLOBAL VASCULAR ACCESS DEVICES FOR OTHERS MARKET SHARE BY REGION, 2022 VS 2030 (%)
• 19. GLOBAL VASCULAR ACCESS DEVICES MARKET SHARE BY REGION, 2022 VS 2030 (%)
• 20. US VASCULAR ACCESS DEVICES MARKET SIZE, 2022-2030 ($ MILLION)
• 21. CANADA VASCULAR ACCESS DEVICES MARKET SIZE, 2022-2030 ($ MILLION)
• 22. UK VASCULAR ACCESS DEVICES MARKET SIZE, 2022-2030 ($ MILLION)
• 23. FRANCE VASCULAR ACCESS DEVICES MARKET SIZE, 2022-2030 ($ MILLION)
• 24. GERMANY VASCULAR ACCESS DEVICES MARKET SIZE, 2022-2030 ($ MILLION)
• 25. ITALY VASCULAR ACCESS DEVICES MARKET SIZE, 2022-2030 ($ MILLION)
• 26. SPAIN VASCULAR ACCESS DEVICES MARKET SIZE, 2022-2030 ($ MILLION)
• 27. REST OF EUROPE VASCULAR ACCESS DEVICES MARKET SIZE, 2022-2030 ($ MILLION)
• 28. INDIA VASCULAR ACCESS DEVICES MARKET SIZE, 2022-2030 ($ MILLION)
• 29. CHINA VASCULAR ACCESS DEVICES MARKET SIZE, 2022-2030 ($ MILLION)
• 30. JAPAN VASCULAR ACCESS DEVICES MARKET SIZE, 2022-2030 ($ MILLION)
• 31. SOUTH KOREA VASCULAR ACCESS DEVICES MARKET SIZE, 2022-2030 ($ MILLION)
• 32. REST OF ASIA-PACIFIC VASCULAR ACCESS DEVICES MARKET SIZE, 2022-2030 ($ MILLION)
• 33. REST OF THE WORLD VASCULAR ACCESS DEVICES MARKET SIZE, 2022-2030 ($ MILLION)

Title: Global Vascular Access Devices Market Size, Share & Trends Analysis Report by Device Type (Central Vascular Access Devices, Peripherally Inserted Central Catheters, Percutaneous Non-tunneled Catheters, Other Central Vascular Access Devices, Peripheral Vascular Access Devices, Peripheral Catheter, Midline Catheter, Others), by Application (Administration of Drugs, Administration of Fluid and Nutrition, Diagnostics and Testing, and Others), and by End User (Hospital and Clinic, Diagnostic Centers, and Others),Forecast Period (2023-2030).

The global vascular access devices market is anticipated to grow at a CAGR of 6.11% during the Forecast Period (2023-2030). The market's growth is attributed to increasing healthcare expenses across the globe. The demand for innovative medical devices, such as vascular access devices, has been driven by increased healthcare spending in both developed and developing nations. Accordingly market players are coming up with new products to cater the demand for peripheral vascular access system. For instance, in April 2023, BD (Becton, Dickinson and Company) launched the BD Prevue™ II Peripheral Vascular Access System, an ultrasound guided method that can boost the effectiveness and security of IV access needlesticks. The BD prevue II vascular access system has several features. These include real-time needle depth markers, a special probe which enables use without requiring the clinician to alter their view or technique, a virtual display of the needle trajectory with BD Cue™ Needle Tracking Technology, and vessel assessment tools for optimal IV catheter length.

Segmental Outlook

The global vascular access devices market is segmented on the device type, application, and end user. Based on the device type, the market is sub-segmented into central vascular access devices, peripherally inserted central catheters, percutaneous non-tunneled catheters, and others, peripheral vascular access devices, peripheral catheter, midline catheter, and others. Based on the application, the market is sub-segmented into administration of drugs, administration of fluid and nutrition, diagnostics and testing, and others. Based on the end-user, the market is sub-segmented into hospital and clinic, diagnostic centers, and others. The peripheral catheter subcategory is expected to capture a significant portion of the market share within the device type segment. This is attributed to the significant development that has enabled medical professionals and clinicians to adopt the proper approach to managing VAD-related infections and plan out appropriate therapy is the increasing prevalence of diagnosis of VAD-related infection.

The Hospital and Clinic Sub-Segment is Anticipated to Hold a Considerable Share of the Global Vascular Access Devices Market

Among the end user, the hospital and clinic sub-segment is expected to hold a considerable share of the global vascular access devices market. The segmental growth is attributed to the growing demand for vascular access devices. Healthcare facilities are striving to improve the quality of care for vascular surgical and interventional therapy, that is anticipated to raise demand for advanced vascular access tools. Such devices play an essential role in therapeutic regimens since they are necessary for diagnosing and treating vascular diseases. Accordingly market players are coming up with new products to cater the demand for inpatient vascular therapy. For instance, in March 2023, The American College of Surgeons (ACS), with the Society for Vascular Surgery (SVS) launched for patients participating in vascular surgical and interventional therapy in an inpatient setting, a new national quality verification program aims to assist participating hospitals to enhance outcomes and providing the most effective care.

Regional Outlook

The global Vascular Access Devices market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America). Among these, Asia-Pacific is anticipated to hold a prominent share of the market across the globe, owing to the local distributors with established networks in the region and a competitive edge in the vascular access device industry can increase the market.

The North America Region is Expected to Grow at a Significant CAGR in the Global Vascular Access Devices Market

Among all regions, the North America regions is anticipated to grow at a considerable CAGR over the forecast period. Regional growth is attributed to the vascular access catheters are used frequently in the region. The data indicates that vascular access catheters, such as peripherally inserted central catheters, midline catheters, and arterial lines, are used frequently in clinical practice. It indicates that the same types of technologies are essential. According to the National Institute of Health (Gov.), in March 2022, 53.1% of all patients that received a vascular access catheter inserted were female, with a mean age of 34.2 years and admission to critical care services owing to sepsis (90.2%) and cardiovascular issues. With a success rate of 66% on the initial puncture, the placement of the peripherally inserted central catheter, midline, and arterial was echo-guided between 91% and 100%. The midline catheter possessed a reach of 57% through the completion of the treatment, while the average length of the peripherally implanted central catheter was 25.3 days. Overall phlebitis was reported per catheter day at a rate of 2.03, positive blood culture of the central peripheral insertion device at a rate of 1.9, thrombosis at a rate of 0.50, and arterial line thrombosis at a rate of 11.7. According to the reasonable and structured therapeutic uses of the aforementioned elements in accordance with the complexity of the patients admitted to the hospital, the Vascular Access Device Program, led by nurses, reported on that are concerned. To reduce infection rates and thrombosis through efficient follow-up and control mechanisms, improvement strategies needs to be implemented into action.

Furthermore, the market's growth is attributed to clinical advice and adoption across the region. Specific vascular access devices can be adopted in response to clinical advice and support from medical professionals. Market expansion can be encouraged by favorable reviews and suggestions for the Arrow Pressure Injectable Midline product. in September 2022, Teleflex Incorporated introduces their new Arrow Pressure Injectable Midline portfolio in the US and Canada in an effort to reduce line identification uncertainty. Clinicians offer a choice between the standard Arrow Midline and the antibacterial and antithrombogenic Arrowg+ard Blue Advance Midline, both of that come in single and double lumen designs.

Market Players Outlook

The major companies serving the vascular access devices market include: Baxter Healthcare Corp., Cook Group Inc., Fresenius Medical Care India Private Ltd., India Medtronic Pvt Ltd., Nipro Medical Corp., others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in September 2021, Access Vascular, Inc. and the Association for Vascular Access (AVA) has partnered strategically. The partnership's objective is to work jointly to improve patient outcomes through the use of clinical education and evidence-based clinical practices.

The Report Covers:

• Market value data analysis of 2022 and forecast to 2030.
• Annualized market revenues ($ million) for each market segment.
• Country-wise analysis of major geographical regions.
• Key companies operating in the global vascular access devices market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
• Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
• Analysis of market-entry and market expansion strategies.
• Competitive strategies by identifying 'who-stands-where' in the market.

Table of Contents

1. Report Summary

• Current Industry Analysis and Growth Potential Outlook
• 1.1. Research Methods and Tools
• 1.2. Market Breakdown
  • 1.2.1. By Segments
  • 1.2.2. By Region

2. Market Overview and Insights

• 2.1. Scope of the Report
• 2.2. Analyst Insight & Current Market Trends
  • 2.2.1. Key Findings
  • 2.2.2. Recommendations
  • 2.2.3. Conclusion

3. Competitive Landscape

• 3.1. Key Company Analysis
• 3.2. Access Vascular, Inc.
  • 3.2.1. Overview
  • 3.2.2. Financial Analysis
  • 3.2.3. SWOT Analysis
  • 3.2.4. Recent Developments
• 3.3. B. Braun SE
  • 3.3.1. Overview
  • 3.3.2. Financial Analysis
  • 3.3.3. SWOT Analysis
  • 3.3.4. Recent Developments
• 3.4. Becton, Dickinson, and Co.
  • 3.4.1. Overview
  • 3.4.2. Financial Analysis
  • 3.4.3. SWOT Analysis
  • 3.4.4. Recent Developments
• 3.5. Key Strategy Analysis

4. Market Segmentation

• 4.1. Global Vascular Access Devices Market by Device Type
  • 4.1.1. Central Vascular Access Devices
    • 4.1.1.1. Peripherally Inserted Central Catheters
    • 4.1.1.2. Percutaneous Non-tunneled Catheters
    • 4.1.1.3. Other Central Vascular Access Devices
  • 4.1.2. Peripheral Vascular Access Devices
    • 4.1.2.1. Peripheral Catheter
    • 4.1.2.2. Midline Catheter
    • 4.1.2.3. Other Peripheral Vascular Access Devices
• 4.2. Global Vascular Access Devices Market by Application
  • 4.2.1. Administration of Drugs
  • 4.2.2. Administration of Fluid and Nutrition
  • 4.2.3. Diagnotics and Testing
  • 4.2.4. Others ( Emergency and Critical Care, and Intravenous (IV) Therapy )
• 4.3. Global Vascular Access Devices Market by End-User
  • 4.3.1. Direct Fired
  • 4.3.2. Indirect Fired
  • 4.3.3. Water Driven
• 4.4. Global Vascular Access Devices Market by End-User
  • 4.4.1. Hospital/Clinic
  • 4.4.2. Diagnostic Centers
  • 4.4.3. Others ( Home Healthcare Agencies, Nursing Homes, and Diagnostic and Imaging Centers)

5. Regional Analysis

• 5.1. North America
  • 5.1.1. United States
  • 5.1.2. Canada
• 5.2. Europe
  • 5.2.1. UK
  • 5.2.2. Germany
  • 5.2.3. Italy
  • 5.2.4. Spain
  • 5.2.5. France
  • 5.2.6. Rest of Europe
• 5.3. Asia-Pacific
  • 5.3.1. China
  • 5.3.2. India
  • 5.3.3. Japan
  • 5.3.4. South Korea
  • 5.3.5. Rest of Asia-Pacific
• 5.4. Rest of the World

6. Company Profiles

• 6.1. Baxter Healthcare Corp.
• 6.2. Cook Group Inc.
• 6.3. Fresenius Medical Care India Private Ltd.
• 6.4. India Medtronic Pvt Ltd.
• 6.5. Nipro Medical Corp.
• 6.6. Siemens Healthineers co.
• 6.7. Smiths Group
• 6.8. Statement Introduction
• 6.9. Teleflex Inc.
• 6.10. Terumo Group